Research Article
T, B, and NKT Cells in Systemic Inflammation in Obstructive Sleep Apnoea
Table 1
Demographic data, results of polysomnographic tests and metabolic characteristic of patients with OSA (data expressed as mean ± SD).
| Patients number | 48 |
| Age (years, mean, [range]) |
58.5 [36–82] |
| Sex (female/male) | 15 : 33 |
| Smokers (,%) | 35% |
| Mean pack years |
5.80 ± 10.54 |
| BMI (kg/m2) | 31.68 ± 6.75 |
| Obesity (%) | 56% |
| AHI (h−1) | 52.92 ± 21.02 (8–110) |
| sAHI (%) | 92% |
| ODI | 31.11 ± 18.51 |
| SpO2 Lowest Mean |
76.06 ± 8.40% 90.88 ± 3.20% |
| ESS | 12.23 ± 5.23 (2–21) |
| WBC (×103/L) | 7.08 ± 1.78 |
| Hb (g/L) | 14.51 ± 1.34 |
| CRP (mg/L) | 4.35 ± 6.45 |
| Total cholesterol (mg/dL) | 196.02 ± 38.73 |
| HDL-C (mg/dL) | 50.10 ± 14.03 |
| TG (mg/dL) | 160.4 ± 124.03 |
| Hypertension (%) | 71% |
| Diabetes (%) | 17% |
| Ischemic heart disease (%) | 21% |
| COPD (%) | 8% |
| Metabolic syndrome | 56% |
|
|
AHI: apnea/hypopnea index; sAHI: severe OSA; ODI: oxygen desaturation index; ESS: Epworth Sleepiness Scale; SpO2: peripheral capillary oxygen saturation; HDL-C: high density lipoprotein cholesterol; TG: triglycerides; COPD: chronic obstructive pulmonary disease.
|